NIH-funded research R01 grant

Investigating immune responses in TB meningitis among HIV-infected individuals

Official title: TB Meningitis: Evaluating CSF Immunology to Discover Hidden Disease and Potential Immunomodulatory Therapies

Funded at University of Minnesota · NIH-10888216 · Data updated 2026-11-12

This study is looking at how the immune system responds in people with tuberculous meningitis who also have HIV, to find out what helps them do better or worse, with the hope of improving diagnosis and treatment options for patients in Uganda.

More Meningitis research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Minnesota
NIH-funded
Lab location1 site (Minneapolis, United States)
Project startAugust 1, 2021
Project endJuly 31, 2026
Funding year2024
Award (this year)$649,938
NIH project number5R01AI162786-04
Project IDNIH-10888216 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are adults over 21 years old who are living with HIV and have been diagnosed with or are suspected to have tuberculous meningitis.

Less likely to help

Patients who are not living with HIV or do not have tuberculous meningitis may not benefit from this research.

What this research studies

This research focuses on understanding the immune responses in patients with tuberculous meningitis (TBM) who are also living with HIV. It aims to identify the specific immune signatures that are associated with better or worse outcomes in these patients. By utilizing advanced diagnostic techniques, the study seeks to improve the detection of TBM and explore potential immunomodulatory therapies that could enhance treatment effectiveness. The research team, experienced in clinical and translational studies, will conduct this work primarily in Uganda, where the burden of TBM is significant.

Why it matters

Potential benefit: If successful, this research could lead to improved diagnosis and treatment options for patients suffering from TB meningitis, particularly those with HIV.

How similar studies have gone: Other research has shown promise in understanding immune responses in TBM, but this specific approach focusing on HIV-infected individuals is relatively novel.

Where this research is happening

  • University of Minnesota
    Minneapolis, United States
    Active

Researchers

  • Principal investigator: Boulware, David R — University of Minnesota
  • Study coordinator: Boulware, David R

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.